Ventricular arrhythmias in heart failure.

W P Batsford, L L Mickleborough, J A Elefteriades
Author Information
  1. W P Batsford: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520-8017, USA.

Abstract

The management of ventricular arrhythmias in patients with heart failure continues to pose many challenges. Three principles of therapy can be identified: (1) Empiric therapy is not warranted for asymptomatic ventricular arrhythmias. (2) Therapy for asymptomatic ventricular arrhythmias must be individualized. Appropriate management of the underlying cardiac disease is critical, and careful identification of therapeutic goals is necessary. (3) Patients at high risk should be included in prospective, controlled clinical trials whenever possible.

MeSH Term

Anti-Arrhythmia Agents
Arrhythmias, Cardiac
Death, Sudden, Cardiac
Defibrillators, Implantable
Electrocardiography
Heart Failure
Humans
Randomized Controlled Trials as Topic
Signal Processing, Computer-Assisted

Chemicals

Anti-Arrhythmia Agents

Word Cloud

Created with Highcharts 10.0.0arrhythmiasventricularmanagementheartfailuretherapyasymptomaticpatientscontinuesposemanychallengesThreeprinciplescanidentified:1Empiricwarranted2TherapymustindividualizedAppropriateunderlyingcardiacdiseasecriticalcarefulidentificationtherapeuticgoalsnecessary3PatientshighriskincludedprospectivecontrolledclinicaltrialswheneverpossibleVentricular

Similar Articles

Cited By